Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

PC-associated alopecia has unique microscopic features.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

TIP39 and PTH2R help control calcium levels and skin cell development.

TPA is about 50 times more effective at promoting tumors than MZ.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Using thigh skin, doctors successfully rebuilt a woman's scalp after removing a large tumor, with no tumor return after 8 months.

PRP injections are not effective for long-term treatment of temporal triangular alopecia.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Targeting PTEN can improve healing in venous leg ulcers.

Targeting TRP channels may help reduce excessive scarring.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

A new method improves platelet testing for heart disease patients.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Hair shaft changes may be linked to CCCA, but their role is unclear.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.